# Diabetes Research Hub — Iterate Run Report

**Date:** 2026-08-07 (Friday — not Monday, so no weekly PubMed sweep per SKILL Step 2)
**Agent:** Automated research-synthesis iterate agent
**Corpus:** 286 papers (273 VETTED / 13 FLAGGED / 0 UNVETTED)

## Work queue items processed (5)

### 1. Credibility sweep (Step 4 — every run) — CLEAN
Grepped all Analysis/Scripts/*.py:
- No fabricated PMIDs (none >= 42,000,000)
- No "zero SAE" / "zero rejection" claims
- Only "curative" hits are the detector regex inside verify_before_deploy.py (by design)

### 2. Re-vet oldest VETTED papers for claim drift (queue item 38)
Re-checked the 15 oldest last_checked VETTED papers (dated 2026-04-18 -> 2026-04-20) against paper_library/index.json (262 entries):
- All 15 PMIDs present in the index
- 0 title/claim drift (normalized-title match)
- last_checked refreshed for all 15

PMIDs: 22109896, 22296077, 22315720, 22336824, 22349456, 23223116, 23738527, 23780460, 23835325, 23835333, 23890997, 24056026, 24506867, 24508508, 24598244.

### 3. Validate path — TXNIP_NLRP3_beta_cell_DKD (queue item 3 recommendation)
Result: REAFFIRMED PARTIALLY_VALIDATED (preclinical HIGH; clinical EARLY_PHASE1_SAFETY_ONLY). No promotion.
Added three confirming 2025-26 sources:
- PMID 40020889 — UPR-activated NLRP3 drives pyroptotic + apoptotic podocyte injury via CHOP-TXNIP axis in DKD.
- EGCG DKD (PMC11666909) — EGCG ameliorates DKD by inhibiting TXNIP/NLRP3/IL-1beta.
- NLRP3-in-diabetes review (PMC12395217, 2025-26) — SR unifying oxidative-stress -> TXNIP -> NLRP3 across beta cells + complications.
No promotion: mechanism preclinical; no human interventional TXNIP-inhibitor outcome trial (TIX100 early-phase safety only).

### 4. Audit Gap #12 (Treg/CAR-T x Diabetic Neuropathy, SILVER) — REMAINS SILVER
2026 CAR-Treg landscape (BioCells 2026; PMC12661798 CAR-T in T1D) = T1D/autoimmune focus. No CAR-Treg/polyclonal-Treg interventional trial in diabetic peripheral neuropathy. No 2nd independent interventional source -> no GOLD. Next audit ~2026-09-07.

### 5. Audit Gap #4 (Islet Transplant x Personalized Nutrition, SILVER) — REMAINS SILVER
Personalized-nutrition RCTs exist in IGR/cardiometabolic populations (Nat Med 2024; Sci Rep 2024); post-TP-IAT nutrition guidance exists (PMID 33002260). Still no RCT combining islet transplantation with a personalized-nutrition protocol measuring graft/metabolic outcomes. Next audit ~2026-09-07.

## Pipeline rebuild (Step 5)
run_quality_improvements.py -> All 41 improvements [OK]. No failures.

## Git status
Local commit attempted. Push remains BLOCKED — sandbox has no GitHub auth (could not read Username for https://github.com). All changes saved to disk regardless. User must run git push from local PowerShell at C:\Users\justi\OneDrive\Diabetes_Research.

## Constraints honored
No fabricated PMIDs/citations/data. No overstated preclinical evidence. All claims trace to a source. UTF-8 writes. Research synthesis, NOT medical advice.
